Manini, Alex Francis
- Icahn School of Medicine at Mount Sinai · Emergency Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,407
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Emergency Medicine
NIH Funding · FY2023
Linked Award Amount
$1.2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#8,407
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Manini, Alex Francis as a PI. Multi-PI records show the full award amount for context.
- 5R01DA048009-04R01Contact PIPredicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)Icahn School of Medicine at Mount Sinai · Emergency Medicine (NIH department code)$661.7Kaward amount
- 3R01DA048009-04S1R01Contact PICDC supplement year 2Icahn School of Medicine at Mount Sinai · Emergency Medicine (NIH department code)$500Kaward amount
Award organization
Organizations that administered FY2023 awards listing Manini, Alex Francis as a PI.
FY2023 award administered by Icahn School of Medicine at Mount Sinai (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardIcahn School of Medicine at Mount Sinai
- 2011$500K Cumulative Funding
- 2013R01 Grant Holder
- 2014$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #8234
- 2021$5M Cumulative Funding